Russell Investments Group, Ltd. Aravive, Inc. Transaction History

Russell Investments Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$5.11 - $9.24 $24,154 - $43,677	-4,727 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$4.7 - $12.06 $22,216 - $57,007	4,727 New	4,727 $22,000
Q1 2019 May 13, 2019	SELL	$3.35 - $8.27 $12,381 - $30,565	-3,696 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$3.23 - $8.7 $11,938 - $32,155	3,696 New	3,696 $13,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.